These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 34930304

  • 1. 3D hESC exosomes enriched with miR-6766-3p ameliorates liver fibrosis by attenuating activated stellate cells through targeting the TGFβRII-SMADS pathway.
    Wang N, Li X, Zhong Z, Qiu Y, Liu S, Wu H, Tang X, Chen C, Fu Y, Chen Q, Guo T, Li J, Zhang S, Zern MA, Ma K, Wang B, Ou Y, Gu W, Cao J, Chen H, Duan Y.
    J Nanobiotechnology; 2021 Dec 20; 19(1):437. PubMed ID: 34930304
    [Abstract] [Full Text] [Related]

  • 2. Umbilical cord mesenchymal stem cell-derived exosomes inhibits fibrosis in human endometrial stromal cells via miR-140-3p/FOXP1/Smad axis.
    Song M, Ma L, Zhu Y, Gao H, Hu R.
    Sci Rep; 2024 Apr 09; 14(1):8321. PubMed ID: 38594471
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inhibitory Effect of a Human MicroRNA, miR-6133-5p, on the Fibrotic Activity of Hepatic Stellate Cells in Culture.
    Hamada-Tsutsumi S, Onishi M, Matsuura K, Isogawa M, Kawashima K, Sato Y, Tanaka Y.
    Int J Mol Sci; 2020 Oct 01; 21(19):. PubMed ID: 33019495
    [Abstract] [Full Text] [Related]

  • 5. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
    Yu F, Chen B, Fan X, Li G, Dong P, Zheng J.
    Cell Physiol Biochem; 2017 Oct 01; 43(6):2242-2252. PubMed ID: 29073595
    [Abstract] [Full Text] [Related]

  • 6. Mesenchymal stem cell-originated exosomal circDIDO1 suppresses hepatic stellate cell activation by miR-141-3p/PTEN/AKT pathway in human liver fibrosis.
    Ma L, Wei J, Zeng Y, Liu J, Xiao E, Kang Y, Kang Y.
    Drug Deliv; 2022 Dec 01; 29(1):440-453. PubMed ID: 35099348
    [Abstract] [Full Text] [Related]

  • 7. Hydroxysafflor yellow A exerts anti-fibrotic and anti-angiogenic effects through miR-29a-3p/PDGFRB axis in liver fibrosis.
    Xue X, Li Y, Zhang S, Yao Y, Peng C, Li Y.
    Phytomedicine; 2024 Sep 01; 132():155830. PubMed ID: 38959553
    [Abstract] [Full Text] [Related]

  • 8. Ligustrazine Attenuates Liver Fibrosis by Targeting miR-145 Mediated Transforming Growth Factor-β/Smad Signaling in an Animal Model of Biliary Atresia.
    Qiu JL, Zhang GF, Chai YN, Han XY, Zheng HT, Li XF, Duan F, Chen LY.
    J Pharmacol Exp Ther; 2022 Jun 01; 381(3):257-265. PubMed ID: 35398813
    [Abstract] [Full Text] [Related]

  • 9. Serum Exosome-Derived microRNA-193a-5p and miR-381-3p Regulate Adenosine 5'-Monophosphate-Activated Protein Kinase/Transforming Growth Factor Beta/Smad2/3 Signaling Pathway and Promote Fibrogenesis.
    Wang S, Chen Y, Lei G, Ma X, An L, Wang H, Song Z, Lin L, He Q, Xu R, Zhan X, Bai Z, Yang Y.
    Clin Transl Gastroenterol; 2024 Feb 01; 15(2):e00662. PubMed ID: 38099588
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Blocking exosomal miRNA-153-3p derived from bone marrow mesenchymal stem cells ameliorates hypoxia-induced myocardial and microvascular damage by targeting the ANGPT1-mediated VEGF/PI3k/Akt/eNOS pathway.
    Ning W, Li S, Yang W, Yang B, Xin C, Ping X, Huang C, Gu Y, Guo L.
    Cell Signal; 2021 Jan 01; 77():109812. PubMed ID: 33164880
    [Abstract] [Full Text] [Related]

  • 12. Twist1-induced miR-199a-3p promotes liver fibrosis by suppressing caveolin-2 and activating TGF-β pathway.
    Yang X, Ma L, Wei R, Ye T, Zhou J, Wen M, Men R, Aqeilan RI, Peng Y, Yang L.
    Signal Transduct Target Ther; 2020 Jun 05; 5(1):75. PubMed ID: 32499481
    [Abstract] [Full Text] [Related]

  • 13. Exosomes from adipose-derived mesenchymal stem cells improve liver fibrosis by regulating the miR-20a-5p/TGFBR2 axis to affect the p38 MAPK/NF-κB pathway.
    Gan L, Zheng L, Yao L, Lei L, Huang Y, Zeng Z, Fang N.
    Cytokine; 2023 Dec 05; 172():156386. PubMed ID: 37852157
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy.
    Chen J, Yu Y, Li S, Liu Y, Zhou S, Cao S, Yin J, Li G.
    J Cell Mol Med; 2017 Dec 05; 21(12):3679-3692. PubMed ID: 28766848
    [Abstract] [Full Text] [Related]

  • 15. miR-27b-3p reduces muscle fibrosis during chronic skeletal muscle injury by targeting TGF-βR1/Smad pathway.
    Yao H, Qian J, Bian XT, Guo L, Tang KL, Tao X.
    J Orthop Surg Res; 2024 Jun 02; 19(1):329. PubMed ID: 38825706
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Human Wharton's jelly mesenchymal stem cells derived-exosomes enriched by miR-124 promote an anti-fibrotic response in an experimental model of liver fibrosis.
    Niknam B, Baghaei K, Mahmoud Hashemi S, Hatami B, Reza Zali M, Amani D.
    Int Immunopharmacol; 2023 Jun 02; 119():110294. PubMed ID: 37167639
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. MicroRNA-323a-3p Promotes Pressure Overload-Induced Cardiac Fibrosis by Targeting TIMP3.
    Zhang J, Lang Y, Guo L, Pei Y, Hao S, Liang Z, Su G, Shu L, Liu H, Huang C, Xu J.
    Cell Physiol Biochem; 2018 Jun 02; 50(6):2176-2187. PubMed ID: 30415251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.